PHOENIX, Nov. 17, 2016 /PRNewswire/ -- Avella just announced that the company has transitioned into a new 50,000-square-foot corporate headquarters in Phoenix, Arizona. This move allows the company to conduct its clinical, operational and administrative processes under one roof while maintaining greater scalability for future growth.
Avella employs more than 500 staff members who focus on everything from physician relations to patient education, as well as the actual compounding of complex medications. The company also distributes specialty drugs for serious health conditions like cancer, HIV and Hepatitis C.
The new headquarters includes an 8,000-square-foot clean room which is nearly three times the space available at Avella's previous location. Clean room facilities are designed to meet rigorous quality control metrics that drive sterile, safe development of compounded drugs. Through this expansion, Avella will be able to increase its processing capacity to 10,000 prescriptions per day.
"While this new location is just literally blocks away from our previous headquarters, its impact on our operations and market positioning is far-reaching," said Rebecca Shanahan, CEO of Avella. "One of the biggest challenges Avella has faced to date is the limitations placed on our growth because of space and facility constraints. Now that this is no longer an issue, we can continue to expand our national footprint, serving more patients across the country with powerful therapies and collaborating with large hospitals, health systems and physician groups."
Shanahan also maintains that in spite of the company's rapid growth, Avella has preserved its focus on providing personalized service to both physicians and patients. In satisfaction surveys conducted to date, the pharmacy has consistently received exemplary marks for its service levels.
This news comes on the heels of Avella's recent announcements that it has signed agreements to purchase Advanced Pharma, a Texas-based provider of compounded sterile preparations, and Oncology Plus, a provider of patient-specific chemotherapy admixtures. Both acquisitions will further enhance Avella's compounding capabilities and will position Avella as a leading provider of compounded therapies into the hospital marketplace.
About Avella Specialty Pharmacy Headquartered in Phoenix, Arizona, Avella Specialty Pharmacy is a National Accredited Specialty Pharmacy, providing individualized care and support to patients since 1996. Avella's clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The company offers a nationwide distribution service to complement its retail locations. In 2016, Avella was named Specialty Pharmacy of the Year by NASP, a nationally recognized pharmacy trade committee. Inc. Magazine's 2016 list of the 5,000 fastest-growing private companies in the country included Avella for the tenth consecutive year and also recognized Avella as the fastest-growing woman-led company in 2015. For more information, please visit www.avella.com.